Canakinumab for Atherosclerotic Disease
N Engl J Med
.
2018 Jan 11;378(2):197-8.
doi: 10.1056/NEJMc1714635.
Authors
Alexander M Rothman
1
,
Allison C Morton
2
,
David C Crossman
3
;
MRC-ILA Heart investigators
Affiliations
1
University of Sheffield, Sheffield, United Kingdom
2
HeartCare Western Australia, Bunbury, WA, Australia
3
University of St. Andrews, Fife, United Kingdom dcc7@st-andrews.ac.uk
PMID:
29322756
DOI:
10.1056/NEJMc1714635
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal*
Antibodies, Monoclonal, Humanized
Atherosclerosis*
Humans
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
canakinumab
Grants and funding
G0502131/MRC_/Medical Research Council/United Kingdom